BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ponziani FR, Annicchiarico EB, Siciliano M, D’Aversa F, Pompili M, Gasbarrini A. Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation. World J Gastroenterol 2013; 19(21): 3255-3262 [PMID: 23745027 DOI: 10.3748/wjg.v19.i21.3255]
URL: https://www.wjgnet.com/1948-5182/full/v19/i21/3255.htm
Number Citing Articles
1
Robert S. Brown, Jacqueline G. O'Leary, K. Rajender Reddy, Alexander Kuo, Giuseppe J. Morelli, James R. Burton, R. Todd Stravitz, Christine Durand, Adrian M. Di Bisceglie, Paul Kwo, Catherine T. Frenette, Thomas G. Stewart, David R. Nelson, Michael W. Fried, Norah A. Terrault. Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research networkLiver Transplantation 2016; 22(1): 24 doi: 10.1002/lt.24366
2
Elizabeth C. Verna, Varun Saxena, James R. Burton, Jacqueline G. O’Leary, Jennifer L. Dodge, Richard T. Stravitz, Josh Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent DiseaseTransplantation 2015; 99(8): 1644 doi: 10.1097/TP.0000000000000629